Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Akedo Akedo +60.74%
#3 Velvet Velvet +51.92%
#4 Glidr Glidr +51.75%
#5 DOVU DOVU +48.49%
#6 Black Phoenix Black Phoenix +34.17%
#7 Cross Cross +33.98%
#8 Cap Cap +20.06%
#9 DoubleZero DoubleZero +14.97%
#10 Pieverse Pieverse +9.55%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Clasificación en acciones #39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Precio por acción
$0.995
Última sincronización: 2023-07-07
Capitalización bursátil
$624.98K
Cambio (1 día)
-0.50%
Cambio (1 año)
0.00%
País
US
Comercio H-CYTE, Inc. (HCYT)

Categoría

Healthcare
Ganancias de H-CYTE, Inc. (HCYT)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di H-CYTE, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de H-CYTE, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE